An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

THIRUVANANTHAPURAM: In a major breakthrough, doctors at Sree Chitra Tirunal Institute for Medical Sciences and Technology ...

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A groundbreaking gene-editing therapy developed by Eli Lilly and Verve Therapeutics reduced "bad" LDL cholesterol by up to 62 ...

A research team from the Department of Pathology at the University of Hong Kong's LKS Faculty of Medicine (HKUMed) has discovered that atorvastatin, a widely used cholesterol-lowering drug, could ...

Cancer spreads fast and hits hard, especially when it reaches other organs. Once that happens, treatments become less effective, and survival rates drop. But recent research points to an unexpected ...

Cholesterol-lowering statin medications like Lipitor and Crestor have been the #1 prescribed class of drugs in the U.S. for years. More than 215 million prescriptions add $14 billion to drug company ...